CoChat

Human Cancer Protein-Protein Interaction Network: A Structural Perspective

Open access
Kar, Gozde, Gursoy, Attila, Keskin, Ozlem · 2009 · PLoS Computational Biology

The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.

Abstract

Protein-protein interaction networks provide a global picture of cellular function and biological processes. Some proteins act as hub proteins, highly connected to others, whereas some others have few interactions. The dysfunction of some interactions causes many diseases, including cancer. Proteins interact through their interfaces. Therefore, studying the interface properties of cancer-related proteins will help explain their role in the interaction networks. Similar or overlapping binding sites should be used repeatedly in single interface hub proteins, making them promiscuous. Alternatively, multi-interface hub proteins make use of several distinct binding sites to bind to different partners. We propose a methodology to integrate protein interfaces into cancer interaction networks (ciSPIN, cancer structural protein interface network). The interactions in the human protein interaction network are replaced by interfaces, coming from either known or predicted complexes. We provide a detailed analysis of cancer related human protein-protein interfaces and the topological properties of the cancer network. The results reveal that cancer-related proteins have smaller, more planar, more charged and less hydrophobic binding sites than non-cancer proteins, which may indicate low affinity and high specificity of the cancer-related interactions. We also classified the genes in ciSPIN according to phenotypes. Within phenotypes, for breast cancer, colorectal cancer and leukemia, interface properties were found to be discriminating from non-cancer interfaces with an accuracy of 71%, 67%, 61%, respectively. In addition, cancer-related proteins tend to interact with their partners through distinct interfaces, corresponding mostly to multi-interface hubs, which comprise 56% of cancer-related proteins, and constituting the nodes with higher essentiality in the network (76%). We illustrate the interface related affinity properties of two cancer-related hub proteins: Erbb3, a multi interface, and Raf1, a single interface hub. The results reveal that affinity of interactions of the multi-interface hub tends to be higher than that of the single-interface hub. These findings might be important in obtaining new targets in cancer as well as finding the details of specific binding regions of putative cancer drug candidates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pcbi.1000601

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Representation of PIN,SPIN and iSPIN. In A) proteins in PIN are represented; the ones colored black have PDB IDs and the ones colored blue do not have PDB IDs. In B) The proteins with PDB ID and interactions among them constitutes SPIN. In C) The proteins with PDB ID and protein interface information and their interactions constitutes iSPIN. The zoomed representations give idea about what type of information each network contains; PIN is an abstract representation of interactions, SPIN is a subset of PIN with information of PDB IDs, and iSPIN contains the most detailed information including protein interfaces into network. All the networks are visualized using Cytoscape [76].
Figure 1 Representation of PIN,SPIN and iSPIN. In A) proteins in PIN are represented; the ones colored black have PDB IDs and the ones colored blue do not have PDB IDs. In B) The proteins with PDB ID and interactions among them constitutes SPIN. In C) The proteins with PDB ID and protein interface information and their interactions constitutes iSPIN. The zoomed representations give idea about what type of information each network contains; PIN is an abstract representation of interactions, SPIN is a subset of PIN with information of PDB IDs, and iSPIN contains the most detailed information including protein interfaces into network. All the networks are visualized using Cytoscape [76].CC BY · PubMed Central
Figure 2 Topological properties of SPIN. (A) Degree distribution of proteins, R2 = 0.914 for power law fit (B) Average clustering coefficient (C) Topological coefficients (D) Shortest path length distribution.
Figure 2 Topological properties of SPIN. (A) Degree distribution of proteins, R2 = 0.914 for power law fit (B) Average clustering coefficient (C) Topological coefficients (D) Shortest path length distribution.CC BY · PubMed Central
Figure 3 Molecular function and biological process distribution of cancer & non-cancer genes. (A) Molecular distribution of genes in SPIN (B) Molecular distribution of genes in PIN (C) Biological process distribution in SPIN (D) Biological process distribution in PIN.
Figure 3 Molecular function and biological process distribution of cancer & non-cancer genes. (A) Molecular distribution of genes in SPIN (B) Molecular distribution of genes in PIN (C) Biological process distribution in SPIN (D) Biological process distribution in PIN.CC BY · PubMed Central
Figure 4 Sub-networks in SPIN. SPIN is clustered into sub-networks, proteins are classified into four categories; cancer-hub, noncancer-hub, cancer-nonhub, noncancer-nonhub are displayed in purple, green, blue and white color, respectively. Over-represented molecular functions (if any) are shown for each sub-network.
Figure 4 Sub-networks in SPIN. SPIN is clustered into sub-networks, proteins are classified into four categories; cancer-hub, noncancer-hub, cancer-nonhub, noncancer-nonhub are displayed in purple, green, blue and white color, respectively. Over-represented molecular functions (if any) are shown for each sub-network.CC BY · PubMed Central
Figure 5 Essentiality of different categories of proteins. A) Essentiality in PIN. B) Essentiality in SPIN. C) Essentiality in random network.
Figure 5 Essentiality of different categories of proteins. A) Essentiality in PIN. B) Essentiality in SPIN. C) Essentiality in random network.CC BY · PubMed Central
Figure 6 Essentiality of proteins classified as cancer-hub, cancer-nonhub and non-cancer-hub in SPIN, PIN and random network.
Figure 6 Essentiality of proteins classified as cancer-hub, cancer-nonhub and non-cancer-hub in SPIN, PIN and random network.CC BY · PubMed Central
Figure 7 Representation of iSPIN. The nodes colored in green and red are multi-interface hubs and single-interface hubs, respectively. In the zoomed representation, the interactions of a multi-interface hub; ERBB3 is displayed.
Figure 7 Representation of iSPIN. The nodes colored in green and red are multi-interface hubs and single-interface hubs, respectively. In the zoomed representation, the interactions of a multi-interface hub; ERBB3 is displayed.CC BY · PubMed Central
Figure 8 Representation of ERBB3-NRG1 interaction schematically. The interactions are visualised using VMD [78] A) ERBB3 (1m6b_A) and NRG1 (1hae_A) are shown as newcartoon diagram in blue and red color, respectively. The transparent surface represents the interface region. The labeled residues (represented by their Cα atoms) of 1hae_A are reported to be critical for binding in a previous work [58]; i.e. when they are mutated to alanine, the binding affinity for ERBB3 was significantly reduced. B) HER3 (blue) – pertuzumab heavy chain (yellow) is shown. Pertuzumab shares the same interface with NRG1 (see “An inhibitor affecting Erb signaling pathway: pertuzumab” section).
Figure 8 Representation of ERBB3-NRG1 interaction schematically. The interactions are visualised using VMD [78] A) ERBB3 (1m6b_A) and NRG1 (1hae_A) are shown as newcartoon diagram in blue and red color, respectively. The transparent surface represents the interface region. The labeled residues (represented by their Cα atoms) of 1hae_A are reported to be critical for binding in a previous work [58]; i.e. when they are mutated to alanine, the binding affinity for ERBB3 was significantly reduced. B) HER3 (blue) – pertuzumab heavy chain (yellow) is shown. Pertuzumab shares the same interface with NRG1 (see “An inhibitor affecting Erb signaling pathway: pertuzumab” section).CC BY · PubMed Central
Figure 9 Ribbon diagram and interface representation of ERBB3 interactions with PLCG1, EPOR and ACK1. ERBB3 (1m6b_A), PCLG1 (1hsq_A), EPOR (1eer_B) and ACK1 (1u46_A) are colored in blue, red, pink and orange respectively. Interface residues are shown as spheres. (A) ERBB3-PLCG1 interaction. (B) ERBB3-EPOR interaction. (C) ERBB3-ACK1 interaction.
Figure 9 Ribbon diagram and interface representation of ERBB3 interactions with PLCG1, EPOR and ACK1. ERBB3 (1m6b_A), PCLG1 (1hsq_A), EPOR (1eer_B) and ACK1 (1u46_A) are colored in blue, red, pink and orange respectively. Interface residues are shown as spheres. (A) ERBB3-PLCG1 interaction. (B) ERBB3-EPOR interaction. (C) ERBB3-ACK1 interaction.CC BY · PubMed Central
Figure 10 Ribbon diagram and interface representation of RAF1 interactions with YWHAZ, MAP2K2 and CDC25A. RAF1 (1c1y_B), YWHAZ (1qja_A), MAP2K2 (1s9i_A) and CDC25A (1c25_A) are colored in blue, red, cyan and purple respectively. (A) RAF1-YWHAZ interaction. (B) RAF1-MAP2K2 interaction. (C) RAF1-CDC25A interaction. Interaction interfaces of RAF1 through YWHAZ, MAP2K2 and CDC25A are highly overlapping; the interactions are mutually exclusive.
Figure 10 Ribbon diagram and interface representation of RAF1 interactions with YWHAZ, MAP2K2 and CDC25A. RAF1 (1c1y_B), YWHAZ (1qja_A), MAP2K2 (1s9i_A) and CDC25A (1c25_A) are colored in blue, red, cyan and purple respectively. (A) RAF1-YWHAZ interaction. (B) RAF1-MAP2K2 interaction. (C) RAF1-CDC25A interaction. Interaction interfaces of RAF1 through YWHAZ, MAP2K2 and CDC25A are highly overlapping; the interactions are mutually exclusive.CC BY · PubMed Central
Figure 11 Flowchart representation of the method of mapping interactions to 3D structures and generating iSPIN. The method is applied for all the interactions in the human interactome (PIN).
Figure 11 Flowchart representation of the method of mapping interactions to 3D structures and generating iSPIN. The method is applied for all the interactions in the human interactome (PIN).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Cited by

Items 101–200 of 240

Metadata

Authors
Kar, G., Gursoy, A., & Keskin, O.
Affiliations
Koç University (TR)
Venue
PLoS Computational Biology
Published
2009-12-11
Volume
5
Issue
12
Pages
e1000601
ISSN
  • 1553-734X (ISSN-L)
  • 1553-7358
OpenAlex
W2150066952
Cited by
235
References
83
Citations by year
2026: 3 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 12 · 2020: 7 · 2019: 17 · 2018: 9 · 2017: 26 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 28 · 2012: 17
FWCI
6.18
Type
journal article
Language
en
Open access
Locations
  • PLoS Computational Biology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Collections portal (Koç University) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (104T504)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Keywords
protein-protein interaction network, cancer-related proteins, protein interfaces, binding sites, hub proteins, network topology, binding affinity, binding specificity, breast cancer, colorectal cancer, leukemia, HER3, Raf-1, cancer drug targets
MeSH terms
Animals, Binding Sites, Humans, Models, Molecular, Neoplasms, Protein Binding, Proteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Computational Biology, Protein Interaction Domains and Motifs, Hydrophobic and Hydrophilic Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.